What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News New non-invasive glaucoma therapy makes U.S. debut at Glaucoma Center of San Francisco First U.S. patient receives Eyetronic nerve stimulation for glaucoma; early data expected 2026 as non-invasive therapy shows promise. bySoujanya RaviJuly 21, 2025